These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 7233993

  • 21. Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial.
    Cools HJ, Gussekloo J, Remmerswaal JE, Remarque EJ, Kroes AC.
    J Med Virol; 2009 May; 81(5):908-14. PubMed ID: 19319953
    [Abstract] [Full Text] [Related]

  • 22. Specific antibody response after influenza immunization in systemic lupus erythematosus.
    Abu-Shakra M, Press J, Varsano N, Levy V, Mendelson E, Sukenik S, Buskila D.
    J Rheumatol; 2002 Dec; 29(12):2555-7. PubMed ID: 12465151
    [Abstract] [Full Text] [Related]

  • 23. [Simultaneous vaccination against influenza and invasive pneumococcal disease in chronic dialysis patients].
    Trmal J, Havlícková M, Bícová R, Bitterová Z, Kelerová J.
    Epidemiol Mikrobiol Imunol; 2005 Aug; 54(3):123-8. PubMed ID: 16173523
    [Abstract] [Full Text] [Related]

  • 24. The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice.
    Cox RJ, Hovden AO, Brokstad KA, Szyszko E, Madhun AS, Haaheim LR.
    Vaccine; 2006 Nov 10; 24(44-46):6585-7. PubMed ID: 16839650
    [Abstract] [Full Text] [Related]

  • 25. Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients.
    Pauksen K, Linde A, Hammarström V, Sjölin J, Carneskog J, Jonsson G, Oberga G, Engelmann H, Ljungman P.
    Clin Infect Dis; 2000 Feb 10; 30(2):342-8. PubMed ID: 10671339
    [Abstract] [Full Text] [Related]

  • 26. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years.
    Nabeshima S, Kashiwagi K, Murata M, Kanamoto Y, Furusyo N, Hayashi J.
    J Med Virol; 2007 Mar 10; 79(3):320-5. PubMed ID: 17245715
    [Abstract] [Full Text] [Related]

  • 27. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy.
    Hanania NA, Sockrider M, Castro M, Holbrook JT, Tonascia J, Wise R, Atmar RL, American Lung Association Asthma Clinical Research Centers.
    J Allergy Clin Immunol; 2004 Apr 10; 113(4):717-24. PubMed ID: 15100679
    [Abstract] [Full Text] [Related]

  • 28. Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.
    Wu J, Fang HH, Chen JT, Zhou JC, Feng ZJ, Li CG, Qiu YZ, Liu Y, Lu M, Liu LY, Dong SS, Gao Q, Zhang XM, Wang N, Yin WD, Dong XP.
    Clin Infect Dis; 2009 Apr 15; 48(8):1087-95. PubMed ID: 19281330
    [Abstract] [Full Text] [Related]

  • 29. Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain.
    Droebner K, Haasbach E, Fuchs C, Weinzierl AO, Stevanovic S, Büttner M, Planz O.
    Vaccine; 2008 Dec 09; 26(52):6965-74. PubMed ID: 18848593
    [Abstract] [Full Text] [Related]

  • 30. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly.
    de Jong JC, Beyer WE, Palache AM, Rimmelzwaan GF, Osterhaus AD.
    J Med Virol; 2000 May 09; 61(1):94-9. PubMed ID: 10745239
    [Abstract] [Full Text] [Related]

  • 31. A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.
    Joseph A, Itskovitz-Cooper N, Samira S, Flasterstein O, Eliyahu H, Simberg D, Goldwaser I, Barenholz Y, Kedar E.
    Vaccine; 2006 May 01; 24(18):3990-4006. PubMed ID: 16516356
    [Abstract] [Full Text] [Related]

  • 32. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients.
    Vogtländer NP, Brown A, Valentijn RM, Rimmelzwaan GF, Osterhaus AD.
    Vaccine; 2004 Jun 02; 22(17-18):2199-201. PubMed ID: 15149777
    [Abstract] [Full Text] [Related]

  • 33. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses.
    Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW, Treanor JJ, Walter Reed Health Care System Influenza Vaccine Consortium.
    Arch Intern Med; 2008 Dec 08; 168(22):2405-14. PubMed ID: 19064822
    [Abstract] [Full Text] [Related]

  • 34. An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine.
    Del Giudice G, Hilbert AK, Bugarini R, Minutello A, Popova O, Toneatto D, Schoendorf I, Borkowski A, Rappuoli R, Podda A.
    Vaccine; 2006 Apr 12; 24(16):3063-5. PubMed ID: 16464520
    [Abstract] [Full Text] [Related]

  • 35. [A field experiment with neuraminidase influenza vaccine (author's transl)].
    Janout V, Uvízl M, Kotíková J, Jukl V.
    Cesk Epidemiol Mikrobiol Imunol; 1981 Jul 12; 30(4):203-12. PubMed ID: 6455206
    [No Abstract] [Full Text] [Related]

  • 36. An influenza A/H3 outbreak during the 2004/2005 winter in elderly vaccinated people living in a nursing home.
    Iorio AM, Neri M, Lepri E, Camilloni B, Basileo M, Sigismondi N, Fabiani C, Calzoletti L, Puzelli S, Donatelli I.
    Vaccine; 2006 Nov 10; 24(44-46):6615-9. PubMed ID: 16828941
    [Abstract] [Full Text] [Related]

  • 37. Lymphoblast proliferation and humoral antibody response after rubella vaccination.
    Lalla M, Vesikari T, Virolainen M.
    Clin Exp Immunol; 1973 Oct 10; 15(2):193-202. PubMed ID: 4762016
    [Abstract] [Full Text] [Related]

  • 38. Transcutaneous immunization with inactivated influenza virus induces protective immune responses.
    Skountzou I, Quan FS, Jacob J, Compans RW, Kang SM.
    Vaccine; 2006 Aug 28; 24(35-36):6110-9. PubMed ID: 16766095
    [Abstract] [Full Text] [Related]

  • 39. Antibody response in respiratory secretions of volunteers given live and dead influenza virus.
    Mann JJ, Waldman RH, Togo Y, Heiner GG, Dawkins AT, Kasel JA.
    J Immunol; 1968 Apr 28; 100(4):726-35. PubMed ID: 5645216
    [No Abstract] [Full Text] [Related]

  • 40. Antibody response in humans to deoxycholate-treated influenza virus vaccine.
    Duxbury AE, Hampson AW, Sievers JG.
    J Immunol; 1968 Jul 28; 101(1):62-7. PubMed ID: 5662705
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.